UnitedHealth Group Incorporated (NYSE:UNH) Position Lessened by Seven Mile Advisory

Seven Mile Advisory cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 15.7% in the fourth quarter, Holdings Channel reports. The firm owned 1,583 shares of the healthcare conglomerate’s stock after selling 294 shares during the period. Seven Mile Advisory’s holdings in UnitedHealth Group were worth $801,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter worth about $25,000. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group during the fourth quarter valued at approximately $30,000. Promus Capital LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter worth $32,000. Pillar Financial Advisors LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at $40,000. Finally, DecisionPoint Financial LLC lifted its position in UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after acquiring an additional 62 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on UNH. Wells Fargo & Company cut their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Barclays reduced their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. Truist Financial cut their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Twenty investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $515.47 on Monday. The business’s fifty day moving average is $508.81 and its two-hundred day moving average is $543.92. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The firm has a market cap of $471.51 billion, a P/E ratio of 33.26, a P/E/G ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s revenue was up 6.8% on a year-over-year basis. During the same period in the previous year, the firm posted $5.83 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.63%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.